Oct

01

2024

Hamlet BioPharmas digitala investerarmöte tidigareläggs till den 9 oktober kl. 12:00 CET

Hamlet Biopharma

|

Press releases

Hamlet BioPharma fortsätter sin serie av livesända digitala investerarmöten, där vi presentera pågående arbete inom bolagets breda projektportfölj. Me...

Read more

Sep

26

2024

Positive Phase II study shows similar clinical outcomes of immunotherapy and antibiotic treatment for recurrent acute cystitis, potentially reducing the need for antibiotics

Hamlet Biopharma

|

Press releases

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has success...

Read more

Sep

17

2024

Hamlet BioPharma bjuder in till digitalt investerarmöte den 18 september kl. 12:00

Hamlet Biopharma

|

Press releases

Hamlet BioPharma fortsätter nu serien av livesända digitala investerarmöten, där medarbetare presenterar sitt pågående arbete i bolagets breda projekt...

Read more

Sep

12

2024

The Economist features groundbreaking research on human breast milk and the story of HAMLET

Hamlet Biopharma

|

Press releases

Hamlet BioPharma is pleased to announce a recent article about human breast milk in The Economist, a leading international newspaper. The article hig...

Read more

Sep

11

2024

Alpha1H treatment shows strong effects in patients with bladder cancer in final analysis published in Cancer Medicine

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announces that Hamlet BioPharma’s dr...

Read more

Aug

28

2024

Year-end Report (Q4) July 2023 – June 2024

Hamlet Biopharma

|

Financial, Press releases

    ...

Read more

Aug

27

2024

Hamlet BioPharma bjuder in till pressträff den 28 augusti

Hamlet Biopharma

|

Press releases

Med anledning bolagets bokslutskommuniké för 2023/2024, bjuder Hamlet BioPharma in till en livesänd digital pressträff onsdagen den 28 augusti klockan...

Read more

Aug

22

2024

Invitation to monthly digital events and presentations of quarterly reports

Hamlet Biopharma

|

Press releases

Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportu...

Read more

Jun

28

2024

Hamlet BioPharma, det innovativa läkemedelsbolaget, med en stark portfölj av projekt för behandling av cancer och infektioner, meddelar uppdatering kring pågående kliniska studier

Hamlet Biopharma

|

Press releases

Alpha1H – Blåscancer: Framgångsrika kliniska studier, Fast-track-status och utveckling av FDA dialog mot Fas III studier. Kliniska data visar ...

Read more

Jun

20

2024

Hamlet BioPharma, the innovative pharmaceutical company, with a strong portfolio of projects, for the treatment of cancer and infections, is featured in this weekend issue of The Guardian

Hamlet Biopharma

|

Press releases

Hamlet BioPharma was selected by Media Planet, the media agency for The Guardian, to be featured in the Health Awareness campaign, BLADDER AND BOWEL H...

Read more

May

27

2024

Hamlet BioPharma Participates in The Global Forum 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Gl...

Read more

May

24

2024

Q3 Interim Report January – March 2024

Hamlet Biopharma

|

Financial, Press releases

...

Read more

May

22

2024

Hamlet BioPharma bjuder in till investerarträff

Hamlet Biopharma

|

Press releases

Med anledning bolagets delårsrapport för tredje kvartalet, bjuder Hamlet BioPharma in till en livesänd digital investerarträff fredagen den 24 maj klo...

Read more

May

06

2024

Clinical data from patients with bladder pain syndrome support anakinra (IL1-RA) as a new, successful treatment option

Hamlet Biopharma

|

Press releases

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has success...

Read more

Apr

18

2024

Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group

Hamlet Biopharma

|

Press releases

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, has secured contin...

Read more

Apr

11

2024

Alpha1H to be the first asset for the commercial collaboration

Hamlet Biopharma

|

Press releases

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today t...

Read more

Apr

03

2024

Immune responses in patients treated with Alpha1H – results published in the journal Cancer Medicine

Hamlet Biopharma

|

Press releases

Hamlet BioPharma announced on January 25 that clinical data showed a strong immune response with anti-tumor potential in Alpha1H-treated patients with...

Read more

Mar

27

2024

Hamlet BioPharma arranges a new series of digital events

Hamlet Biopharma

|

Press releases

Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced t...

Read more

Mar

26

2024

Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...

Read more

Mar

06

2024

Hamlet BioPharma Participates in Swiss Nordic Bio 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce its participati...

Read more

Feb

22

2024

Hamlet BioPharma meddelar sista dag för handel med BTA

Hamlet Biopharma

|

Press releases

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN...

Read more

Feb

22

2024

Q2 Interim Report October – December 2023

Hamlet Biopharma

|

Financial, Press releases

...

Read more

Feb

21

2024

Hamlet BioPharma bjuder in till pressträff

Hamlet Biopharma

|

Press releases

Med anledning av bolagets delårsrapport bjuder Hamlet BioPharma in till en livesänd digital pressträff torsdagen den 22 februari klockan 12.00. På pr...

Read more

Feb

14

2024

Hamlet BioPharma Enters Commercial Collaborations with Top International Advisory Firms to Enhance Partnering and Strategic Alliances

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce that it has ent...

Read more

Feb

09

2024

Hamlet BioPharma AB meddelar att bolaget genom företrädesemission tillförs totalt cirka 46,7 MSEK före avdrag för emissionskostnader

Hamlet Biopharma

|

Press releases

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN...

Read more

Feb

02

2024

Storbankerna har kortat ner teckningstiden – du kan fortfarande teckna direkt

Hamlet Biopharma

|

Press releases

Vi har från Hamlet BioPharmas sida uppmärksammat att Storbankerna har satt egna deadlines för anmälan till emissionen. Därför har vissa aktieägare har...

Read more

Jan

25

2024

Nya analyser av kliniska data från Alpha1H-behandlade patienter med cancer i urinblåsan visar på ett starkt immunsvar med anti-tumöreffekter

Hamlet Biopharma

|

Press releases

Hamlet BioPharmas läkemedelskandidat Alpha1H har visat sig påverka en majoritet av tumörerna hos behandlade patienter med cancer i urinblåsan. En ny a...

Read more

Jan

25

2024

Hamlet BioPharmas styrelse, ledning och rådgivare deltar i företrädesemissionen

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB genomför en företrädesemission av B-aktier med möjlighet att säkra cirka 40 MSEK. Vid full teckning tillförs bolaget cirka 80,6 MS...

Read more

Jan

23

2024

Hamlet BioPharma inbjuder till digitala investerarmöten

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, det innovativa läkemedelsbolaget med en stark portfölj av projekt för behandling av cancer och infektioner, genomför en företrädesem...

Read more

Jan

22

2024

Hamlet BioPharma AB offentliggör prospekt i samband med företrädesemission

Hamlet Biopharma

|

Press releases

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN...

Read more

Jan

10

2024

Hamlet BioPharma featured at MSQ’s CEO Webinar series released during the JP Morgan Health Care Conference 2024

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along wi...

Read more

Jan

09

2024

Immunotherapy – a new approach to treating bacterial infections, including antibiotic resistant strains

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along wi...

Read more

Dec

20

2023

Antimicrobial peptide therapy for tuberculosis infections

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along wi...

Read more

Dec

14

2023

Kommuniké från extra bolagsstämma i Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

Vid extra bolagsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 14 december 2023 fattades följande beslut. ...

Read more

Dec

14

2023

Kommuniké från årsstämma i Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

Vid årsstämma i Hamlet BioPharma AB, org.nr 556568-8958, (”Hamlet BioPharma” eller ”Bolaget”) den 14 december 2023 fattades de beslut som beskrivs ned...

Read more

Dec

13

2023

Hamlet BioPharma Announces the Nomination of Elisabeth Parker to its Board of Directors

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along wi...

Read more

Dec

11

2023

Hamlet BioPharma is inviting you to join a digital presentation at Invest Live, Tuesday December 12th at 12.00 CET

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along wi...

Read more

Dec

06

2023

Hamlet BioPharma’s continued development of brain tumor therapy

Hamlet Biopharma

|

Press releases

Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, shares an updat...

Read more

Nov

29

2023

Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer

Hamlet Biopharma

|

Press releases

Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cance...

Read more

Nov

27

2023

Kallelse till extra bolagsstämma i Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till extra bolagsstämma torsdagen den 14 december 2023 klockan 16:30 ...

Read more

Nov

23

2023

Hamlet BioPharma publicerar årsredovisning 2022/2023

Hamlet Biopharma

|

Financial, Press releases

...

Read more

Nov

17

2023

Q1 Interim report July – September 2023

Hamlet Biopharma

|

Financial, Press releases

English   Swedish ...

Read more

Nov

13

2023

KALLELSE TILL ÅRSSTÄMMA I Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

Aktieägarna i Hamlet BioPharma AB (”Bolaget”), org.nr 556568-8958, kallas härmed till årsstämma torsdagen den 14 december 2023 klockan 15:00 på High C...

Read more

Oct

30

2023

Hamlet BioPharma presented at the FS Market event on October 25th

Hamlet Biopharma

|

Press releases

The company was presented by Catharina Svanborg and Jan Zetterberg. To view the presentation, please use the link bekow: https://youtu.be/zkZsCx0y1Qw?...

Read more

Oct

23

2023

Bolagsstämma för Hamlet BioPharma planeras äga rum den 14 december 2023

Hamlet Biopharma

|

Press releases

Hamlet Biopharma vill meddela att bolagets årliga bolagsstämma planeras att äga rum den 14 december 2023. Åsredovisning kommer att offentliggöras inna...

Read more

Oct

20

2023

Professor Gabriela Godaly will present valuable insights into the pressing global issues of tuberculosis and antibiotic resistance at the 178th Nobel Symposium in Chemistry in Stellenbosch, South Africa. The title of the presentation is: “Novel treatment for pulmonary tuberculosis”.

Hamlet Biopharma

|

Press releases

Professor Gabriela Godaly is working with Hamlet BioPharma  to develop  a new therapeutic concept to combat tuberculosis through the use of a bacteric...

Read more

Oct

16

2023

Strong anti-tumor effects detected in Alpha1H treated patients, for a combination of clinical and molecular endpoints

Hamlet Biopharma

|

Press releases

Hamlet BioPharma, the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces the results for...

Read more

Oct

16

2023

Ändrad tid för investerarmöte i Hamlet BioPharma AB

Hamlet Biopharma

|

Press releases

För att underlätta för alla att delta i mötet med Hamlet BioPharma ändras mötestiden till torsdag den 19:e oktober, 2023, kl 12:00. LÄNK https://us06...

Read more

Oct

11

2023

Martin Erixon återinträder som VD

Hamlet Biopharma

|

Press releases

Styrelsen har idag utsett Martin Erixon till tillförordnad (tf) VD vilket innebär att Martin Erixon återinträder i sin VD roll. Han ersätter därvid Pe...

Read more

Oct

09

2023

Hamlet BioPharma håller digitalt investerarmöte

Hamlet Biopharma

|

Press releases

Med anledning av höstförkylning kan Catharina Svanborg inte medverka på Aktiedagen, Aktiespararna idag. Därför bjuder Hamlet BioPharma in till ett dig...

Read more